Natera, Inc. (NTRA) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Natera, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.790 -- 00:00:05.875 Welcome to Natera's 2025 fourth quarter financial results conference 00:00:05.875 -- 00:00:10.380 call. At this time, all participants are in a listen-only mode. 00:00:10.380 -- 00:00:15.686 Following management's prepared remarks, we will hold a Q&A session. 00:00:15.686 -- 00:00:21.532 To ask a question at that time, please press star followed by one on your touchtone phone. 00:00:21.532 -- 00:00:26.177 If anyone has difficulty hearing the conference, please press star zero for operator 00:00:26.177 -- 00:00:33.046 assistance. As a reminder, this call is being recorded today, February 26, 2026. 00:00:33.168 -- 00:00:38.633 I would now like to turn the conference over to Michael Brophy, Chief Financial 00:00:38.633 -- 00:00:42.476 Officer. Michael, please go ahead. 00:00:42.476 -- 00:00:46.220 Thanks, operator. Good afternoon. Thank you for joining our conference call to discuss 00:00:46.220 -- 00:00:49.062 the results of our fourth quarter of 2025. 00:00:49.062 -- 00:00:54.087 On the line, I'm joined by Steve Chapman, our CEO, Solomon Moskovitz, President, Clinical 00:00:54.087 -- 00:00:55.628 Diagnostics, 00:00:55.628 -- 00:01:00.555 Alex Alessian, General Manager of Oncology, and our Chief Medical Officer, and John Sesko, 00:01:00.555 -- 00:01:05.447 President, Chief Business Officer. Today's conference call is being broadcast live via 00:01:05.447 -- 00:01:10.876 webcast. We will be referring to a slide presentation that has been posted to investor.notterra.com. 00:01:11.102 -- 00:01:16.289 A replay of the call will also be posted to our IR site as soon as it's available. 00:01:16.289 -- 00:01:20.033 Starting on slide two, during the course of this conference call, we will be making forward-looking 00:01:20.033 -- 00:01:23.917...